saralasin and Thrombosis

saralasin has been researched along with Thrombosis* in 1 studies

Other Studies

1 other study(ies) available for saralasin and Thrombosis

Article	Year
Mechanism of renal hypertension. Lancet (London, England), 1976, Jun-05, Volume: 1, Issue:7971 Renal hypertension of the two-kidney type is divided into three stages. In the first, hypertension results from the vasoconstrictor effect of angiotensin II. This persists to some extent in the second phase but there is in addition a slow-developing pressor effect, also resulting from angiotensin II and probably attributable to sodium. In the first two phases removal of the abnormal kidney corrects the hypertension. This fails in the third phase because changes in the opposite kidney maintain hypertension. Renin and angiotensin are probably not involved at this stage. Topics: Angiotensin II; Animals; Blood Pressure; Dogs; Female; Humans; Hypertension, Renal; Kidney; Models, Biological; Nephrectomy; Renal Artery; Renal Artery Obstruction; Renin; Saralasin; Sodium; Thrombosis; Vasoconstrictor Agents	1976

Article

Year

Lancet (London, England), 1976, Jun-05, Volume: 1, Issue:7971

Renal hypertension of the two-kidney type is divided into three stages. In the first, hypertension results from the vasoconstrictor effect of angiotensin II. This persists to some extent in the second phase but there is in addition a slow-developing pressor effect, also resulting from angiotensin II and probably attributable to sodium. In the first two phases removal of the abnormal kidney corrects the hypertension. This fails in the third phase because changes in the opposite kidney maintain hypertension. Renin and angiotensin are probably not involved at this stage.

Topics: Angiotensin II; Animals; Blood Pressure; Dogs; Female; Humans; Hypertension, Renal; Kidney; Models, Biological; Nephrectomy; Renal Artery; Renal Artery Obstruction; Renin; Saralasin; Sodium; Thrombosis; Vasoconstrictor Agents

1976